AlphaCrest Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,264
| Closed | -$1.38M | – | 158 |
|
|
2022
Q3 | $1.38M | Sell |
16,264
-6,954
| -30% | -$590K | 0.08% | 414 |
|
|
2022
Q2 | $1.92M | Sell |
23,218
-33,387
| -59% | -$2.77M | 0.09% | 328 |
|
|
2022
Q1 | $4.36M | Buy |
56,605
+33,629
| +146% | +$2.59M | 0.24% | 63 |
|
|
2021
Q4 | $2.03M | Sell |
22,976
-1,665
| -7% | -$147K | 0.08% | 422 |
|
|
2021
Q3 | $1.91M | Buy |
24,641
+17,079
| +226% | +$1.32M | 0.1% | 330 |
|
|
2021
Q2 | $631K | Sell |
7,562
-46,348
| -86% | -$3.87M | 0.03% | 869 |
|
|
2021
Q1 | $4.07M | Buy |
53,910
+21,806
| +68% | +$1.65M | 0.23% | 93 |
|
|
2020
Q4 | $2.82M | Buy |
32,104
+16,017
| +100% | +$1.4M | 0.23% | 98 |
|
|
2020
Q3 | $1.22M | Buy |
16,087
+14,085
| +704% | +$1.07M | 0.13% | 197 |
|
|
2020
Q2 | $247K | Sell |
2,002
-3,831
| -66% | -$473K | 0.04% | 726 |
|
|
2020
Q1 | $493K | Sell |
5,833
-3,592
| -38% | -$304K | 0.06% | 580 |
|
|
2019
Q4 | $797K | Sell |
9,425
-18,069
| -66% | -$1.53M | 0.07% | 482 |
|
|
2019
Q3 | $1.85M | Sell |
27,494
-3,071
| -10% | -$207K | 0.11% | 267 |
|
|
2019
Q2 | $2.62M | Buy |
30,565
+17,089
| +127% | +$1.46M | 0.23% | 96 |
|
|
2019
Q1 | $1.2M | Buy |
13,476
+7,017
| +109% | +$623K | 0.18% | 136 |
|
|
2018
Q4 | $550K | Buy |
+6,459
| New | +$550K | 0.16% | 206 |
|